Gyre Therapeutics (GYRE) Change in Receivables (2012 - 2026)
Gyre Therapeutics (GYRE) reported Change in Receivables of -$8.6 million for Q1 2026, down 1287.4% year-over-year from $722000.0 in Q1 2025, and down 277.68% on a QoQ basis from $4.8 million in Q4 2025.
Gyre Therapeutics (GYRE) has 13 years of Change in Receivables data on file, last reported at -$8.6 million in Q1 2026.
- Quarterly Change in Receivables fell 1287.4% year-over-year to -$8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 590.86% YoY) and the FY2025 annual result came in at $10.8 million, up 105.55% from the prior year.
- Change in Receivables declined to -$8.6 million in Q1 2026 per GYRE's latest filing, from $4.8 million in the prior quarter.
- Across five years, Change in Receivables topped out at $4.8 million in Q4 2025 and bottomed at -$8.6 million in Q1 2026.
- The 5-year median for Change in Receivables is -$564000.0 (2022), against an average of -$711857.1.
- The widest annual swing landed in 2025, when Change in Receivables surged 321.03%; it then tumbled 1287.4% in 2026.
- Tracing GYRE's Change in Receivables over 5 years: stood at -$564000.0 in 2022, then slumped by 163.3% to -$1.5 million in 2023, then jumped by 177.17% to $1.1 million in 2024, then soared by 321.03% to $4.8 million in 2025, then plunged by 277.68% to -$8.6 million in 2026.
- Per Business Quant, the three latest GYRE Change in Receivables figures stand at -$8.6 million (Q1 2026), $4.8 million (Q4 2025), and $722000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -8.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.57 Mn |
| Mar 31, 2026 | -8.57 Mn |
| Dec 31, 2025 | 4.83 Mn |
| Dec 31, 2025 | 4.83 Mn |
| Mar 31, 2025 | 722,000.00 |
| Mar 31, 2025 | 722,000.00 |
| Dec 31, 2024 | 1.15 Mn |
| Dec 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | -1.49 Mn |
| Dec 31, 2023 | -1.49 Mn |
| Jun 30, 2022 | -564,000.00 |
| Jun 30, 2022 | -564,000.00 |
| Mar 31, 2022 | -1.05 Mn |
| Mar 31, 2022 | -1.05 Mn |
| Dec 31, 2021 | 704,000.00 |
| Dec 31, 2021 | 704,000.00 |
| Sep 30, 2021 | -857,000.00 |
| Sep 30, 2021 | -857,000.00 |
| Jun 30, 2021 | 965,000.00 |
| Jun 30, 2021 | 965,000.00 |
| Mar 31, 2021 | -2.31 Mn |
| Mar 31, 2021 | -2.31 Mn |
| Dec 31, 2020 | 1.76 Mn |
| Dec 31, 2020 | 1.76 Mn |
| Sep 30, 2020 | -433,000.00 |
| Sep 30, 2020 | -433,000.00 |
| Jun 30, 2020 | 622,000.00 |
| Jun 30, 2020 | 622,000.00 |
| Mar 31, 2020 | -13.63 Mn |
| Mar 31, 2020 | -13.63 Mn |
| Dec 31, 2017 | -27,000.00 |
| Dec 31, 2017 | -27,000.00 |
| Sep 30, 2017 | -83,000.00 |
| Sep 30, 2017 | -83,000.00 |
| Jun 30, 2017 | -93,000.00 |
| Jun 30, 2017 | -93,000.00 |
| Mar 31, 2017 | 196,000.00 |
| Mar 31, 2017 | 196,000.00 |
| Dec 31, 2016 | -70,000.00 |
| Dec 31, 2016 | -70,000.00 |
| Sep 30, 2016 | -361,000.00 |
| Sep 30, 2016 | -361,000.00 |
| Jun 30, 2016 | 14,000.00 |
| Jun 30, 2016 | 14,000.00 |
| Mar 31, 2016 | -44,000.00 |
| Mar 31, 2016 | -44,000.00 |
| Dec 31, 2015 | -156,000.00 |
| Dec 31, 2015 | -156,000.00 |
| Sep 30, 2015 | 243,000.00 |
| Sep 30, 2015 | 243,000.00 |
| Jun 30, 2015 | -295,000.00 |
| Jun 30, 2015 | -295,000.00 |
| Mar 31, 2015 | 287,000.00 |
| Mar 31, 2015 | 287,000.00 |
| Dec 31, 2014 | 5,000.00 |
| Dec 31, 2014 | 5,000.00 |
| Sep 30, 2014 | 245,000.00 |
| Sep 30, 2014 | 245,000.00 |
| Jun 30, 2014 | -315,000.00 |
| Jun 30, 2014 | -315,000.00 |
| Mar 31, 2014 | 64,000.00 |
| Mar 31, 2014 | 64,000.00 |
| Dec 31, 2013 | 374,000.00 |
| Dec 31, 2013 | 374,000.00 |
| Sep 30, 2013 | 950,000.00 |
| Sep 30, 2013 | 950,000.00 |
| Jun 30, 2013 | -275,000.00 |
| Jun 30, 2013 | -275,000.00 |
| Mar 31, 2013 | -997,000.00 |
| Mar 31, 2013 | -997,000.00 |
| Dec 31, 2012 | -1.17 Mn |
| Dec 31, 2012 | -1.17 Mn |